SHP-2 Regulates Growth Factor Dependent Vascular Signalling and Function

ISSN: 1875-5607 (Online)
ISSN: 1389-5575 (Print)


Volume 14, 14 Issues, 2014


Download PDF Flyer




Mini-Reviews in Medicinal Chemistry

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 15th of 58 in Chemistry, Medicinal

Submit Abstracts Online Submit Manuscripts Online

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.186
5 - Year: 2.845

SHP-2 Regulates Growth Factor Dependent Vascular Signalling and Function

Author(s): Hanna Mannell and Florian Krotz

Affiliation: Invasive Cardiology, Clinic Starnberg, Oßwaldstr. 1, 82319 Munich, Germany.

Abstract

Cellular responses to the environment are mediated by intracellular signalling pathways monitoring several essential cellular processes, such as proliferation, migration, differentiation and survival. Cellular dysfunction is caused by dysregulation of intracelleular signalling pathways and may ultimately result in pathophysiological conditions. The non- transmembrane protein tyrosine phosphatase SHP-2 has been shown to be important for the control of cellular behaviour. It influences the activity of several growth factor and cytokine dependent signalling pathways by association with growth factor receptors, cell surface adhesion molecules and adaptor molecules such as Gab-1, Grb2 and IRS-1. Upon FGF-2, EGF and insulin stimulation SHP-2 regulates MAPK pathway activation. In addition, SHP-2 is involved in the regulation of cell survival by influencing the PI3-K/Akt pathway upon EGF, IGF and PDGF stimulation. Due to these properties, SHP-2 function has recently gained more interest in vascular processes, such as in the differentiation of cardiac progenitor cells and angiogenic events. Indeed, SHP-2 was shown to positively regulate endothelial cell motility and angiogenesis in vitro and in vivo as well as controlling intracellular pH of endothelial and vascular smooth muscle cells. On the other hand, SHP-2 was also demonstrated to be responsible for down regulation of VEGF receptor 2 activation upon dopamin and collagen stimulation. Finally, mutations in the Ptpn11 gene (encoding SHP-2) underlie the developmental disorders Noonan syndrome and Leopard syndrome characterized by congenital heart disease and hematologic abnormalities. Different mutations in this gene also result in myeloid and lymphoid malignancies. This article summarizes the role of SHP-2 in signalling pathways relevant for vascular biology and associated disorders.

Keywords: SHP-2, protein tyrosine phosphatase, Ptpn11, Noonans syndrome, PI3-K, MAPK, tyrosine phosphorylation, PTP, N-SH2, endothelial cells.

Purchase Online Order Reprints Order Eprints Rights and Permissions

  
  



Article Details

Volume: 14
Issue Number: 6
First Page: 471
Last Page: 483
Page Count: 13
DOI: 10.2174/1389557514999140506094738
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science